img

Global Tuberculosis (TB) Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Tuberculosis (TB) Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

If you have latent tuberculosis, you may need to take only one or two types of TB drug. Active tuberculosis, particularly if it's a drug-resistant strain, will require several drugs at once. The most common medications used to treat tuberculosis include
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide
Tuberculosis (TB) Treatment report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Tuberculosis (TB) Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Active TB and Latent TB are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Tuberculosis (TB) Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Johnson & Johnson
Otsuka Pharmaceutical Co., Ltd
Macleods Pharmaceutical Ltd
Dong-A ST Co., Ltd
Lupin Ltd
Janssen Products, LP
Mylan
Sanofi
Segment by Type
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide

Segment by Application


Active TB
Latent TB
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Tuberculosis (TB) Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Tuberculosis (TB) Treatment introduction, etc. Tuberculosis (TB) Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Tuberculosis (TB) Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Tuberculosis (TB) Treatment
1.1 Tuberculosis (TB) Treatment Market Overview
1.1.1 Tuberculosis (TB) Treatment Product Scope
1.1.2 Tuberculosis (TB) Treatment Market Status and Outlook
1.2 Global Tuberculosis (TB) Treatment Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Tuberculosis (TB) Treatment Market Size by Region (2018-2033)
1.4 Global Tuberculosis (TB) Treatment Historic Market Size by Region (2018-2023)
1.5 Global Tuberculosis (TB) Treatment Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Tuberculosis (TB) Treatment Market Size (2018-2033)
1.6.1 North America Tuberculosis (TB) Treatment Market Size (2018-2033)
1.6.2 Europe Tuberculosis (TB) Treatment Market Size (2018-2033)
1.6.3 Asia-Pacific Tuberculosis (TB) Treatment Market Size (2018-2033)
1.6.4 Latin America Tuberculosis (TB) Treatment Market Size (2018-2033)
1.6.5 Middle East & Africa Tuberculosis (TB) Treatment Market Size (2018-2033)
2 Tuberculosis (TB) Treatment Market by Type
2.1 Introduction
2.1.1 Isoniazid
2.1.2 Rifampin (Rifadin, Rimactane)
2.1.3 Ethambutol (Myambutol)
2.1.4 Pyrazinamide
2.2 Global Tuberculosis (TB) Treatment Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Tuberculosis (TB) Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Tuberculosis (TB) Treatment Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Tuberculosis (TB) Treatment Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Tuberculosis (TB) Treatment Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Tuberculosis (TB) Treatment Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Tuberculosis (TB) Treatment Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Tuberculosis (TB) Treatment Revenue Breakdown by Type (2018-2033)
3 Tuberculosis (TB) Treatment Market Overview by Application
3.1 Introduction
3.1.1 Active TB
3.1.2 Latent TB
3.2 Global Tuberculosis (TB) Treatment Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Tuberculosis (TB) Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Tuberculosis (TB) Treatment Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Tuberculosis (TB) Treatment Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Tuberculosis (TB) Treatment Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Tuberculosis (TB) Treatment Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Tuberculosis (TB) Treatment Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Tuberculosis (TB) Treatment Revenue Breakdown by Application (2018-2033)
4 Tuberculosis (TB) Treatment Competition Analysis by Players
4.1 Global Tuberculosis (TB) Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis (TB) Treatment as of 2022)
4.3 Date of Key Players Enter into Tuberculosis (TB) Treatment Market
4.4 Global Top Players Tuberculosis (TB) Treatment Headquarters and Area Served
4.5 Key Players Tuberculosis (TB) Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Tuberculosis (TB) Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Johnson & Johnson
5.1.1 Johnson & Johnson Profile
5.1.2 Johnson & Johnson Main Business
5.1.3 Johnson & Johnson Tuberculosis (TB) Treatment Products, Services and Solutions
5.1.4 Johnson & Johnson Tuberculosis (TB) Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Johnson & Johnson Recent Developments
5.2 Otsuka Pharmaceutical Co., Ltd
5.2.1 Otsuka Pharmaceutical Co., Ltd Profile
5.2.2 Otsuka Pharmaceutical Co., Ltd Main Business
5.2.3 Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Products, Services and Solutions
5.2.4 Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Otsuka Pharmaceutical Co., Ltd Recent Developments
5.3 Macleods Pharmaceutical Ltd
5.3.1 Macleods Pharmaceutical Ltd Profile
5.3.2 Macleods Pharmaceutical Ltd Main Business
5.3.3 Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Products, Services and Solutions
5.3.4 Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Dong-A ST Co., Ltd Recent Developments
5.4 Dong-A ST Co., Ltd
5.4.1 Dong-A ST Co., Ltd Profile
5.4.2 Dong-A ST Co., Ltd Main Business
5.4.3 Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Products, Services and Solutions
5.4.4 Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Dong-A ST Co., Ltd Recent Developments
5.5 Lupin Ltd
5.5.1 Lupin Ltd Profile
5.5.2 Lupin Ltd Main Business
5.5.3 Lupin Ltd Tuberculosis (TB) Treatment Products, Services and Solutions
5.5.4 Lupin Ltd Tuberculosis (TB) Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Lupin Ltd Recent Developments
5.6 Janssen Products, LP
5.6.1 Janssen Products, LP Profile
5.6.2 Janssen Products, LP Main Business
5.6.3 Janssen Products, LP Tuberculosis (TB) Treatment Products, Services and Solutions
5.6.4 Janssen Products, LP Tuberculosis (TB) Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Janssen Products, LP Recent Developments
5.7 Mylan
5.7.1 Mylan Profile
5.7.2 Mylan Main Business
5.7.3 Mylan Tuberculosis (TB) Treatment Products, Services and Solutions
5.7.4 Mylan Tuberculosis (TB) Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Mylan Recent Developments
5.8 Sanofi
5.8.1 Sanofi Profile
5.8.2 Sanofi Main Business
5.8.3 Sanofi Tuberculosis (TB) Treatment Products, Services and Solutions
5.8.4 Sanofi Tuberculosis (TB) Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Sanofi Recent Developments
6 North America
6.1 North America Tuberculosis (TB) Treatment Market Size by Country (2018-2033)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Tuberculosis (TB) Treatment Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Tuberculosis (TB) Treatment Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Tuberculosis (TB) Treatment Market Dynamics
11.1 Tuberculosis (TB) Treatment Industry Trends
11.2 Tuberculosis (TB) Treatment Market Drivers
11.3 Tuberculosis (TB) Treatment Market Challenges
11.4 Tuberculosis (TB) Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Tuberculosis (TB) Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Tuberculosis (TB) Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Tuberculosis (TB) Treatment Market Size Share by Region (2018-2023)
Table 4. Global Tuberculosis (TB) Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Tuberculosis (TB) Treatment Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Tuberculosis (TB) Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Tuberculosis (TB) Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Tuberculosis (TB) Treatment Revenue Market Share by Type (2018-2023)
Table 9. Global Tuberculosis (TB) Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Tuberculosis (TB) Treatment Revenue Market Share by Type (2024-2033)
Table 11. North America Tuberculosis (TB) Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Tuberculosis (TB) Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Tuberculosis (TB) Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Tuberculosis (TB) Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Tuberculosis (TB) Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Tuberculosis (TB) Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Tuberculosis (TB) Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Tuberculosis (TB) Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Tuberculosis (TB) Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Tuberculosis (TB) Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Tuberculosis (TB) Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Tuberculosis (TB) Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Tuberculosis (TB) Treatment Revenue Market Share by Application (2018-2023)
Table 24. Global Tuberculosis (TB) Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Tuberculosis (TB) Treatment Revenue Market Share by Application (2024-2033)
Table 26. North America Tuberculosis (TB) Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Tuberculosis (TB) Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Tuberculosis (TB) Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Tuberculosis (TB) Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Tuberculosis (TB) Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Tuberculosis (TB) Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Tuberculosis (TB) Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Tuberculosis (TB) Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Tuberculosis (TB) Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Tuberculosis (TB) Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Tuberculosis (TB) Treatment Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Tuberculosis (TB) Treatment Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis (TB) Treatment as of 2022)
Table 39. Date of Key Players Enter into Tuberculosis (TB) Treatment Market
Table 40. Global Tuberculosis (TB) Treatment Key Players Headquarters and Area Served
Table 41. Tuberculosis (TB) Treatment Product Solution and Service
Table 42. Global Tuberculosis (TB) Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Johnson & Johnson Basic Information List
Table 45. Johnson & Johnson Description and Business Overview
Table 46. Johnson & Johnson Tuberculosis (TB) Treatment Products, Services and Solutions
Table 47. Revenue (US$ Million) in Tuberculosis (TB) Treatment Business of Johnson & Johnson (2018-2023)
Table 48. Johnson & Johnson Recent Developments
Table 49. Otsuka Pharmaceutical Co., Ltd Basic Information List
Table 50. Otsuka Pharmaceutical Co., Ltd Description and Business Overview
Table 51. Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Products, Services and Solutions
Table 52. Revenue (US$ Million) in Tuberculosis (TB) Treatment Business of Otsuka Pharmaceutical Co., Ltd (2018-2023)
Table 53. Otsuka Pharmaceutical Co., Ltd Recent Developments
Table 54. Macleods Pharmaceutical Ltd Basic Information List
Table 55. Macleods Pharmaceutical Ltd Description and Business Overview
Table 56. Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Products, Services and Solutions
Table 57. Revenue (US$ Million) in Tuberculosis (TB) Treatment Business of Macleods Pharmaceutical Ltd (2018-2023)
Table 58. Macleods Pharmaceutical Ltd Recent Developments
Table 59. Dong-A ST Co., Ltd Basic Information List
Table 60. Dong-A ST Co., Ltd Description and Business Overview
Table 61. Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Products, Services and Solutions
Table 62. Revenue (US$ Million) in Tuberculosis (TB) Treatment Business of Dong-A ST Co., Ltd (2018-2023)
Table 63. Dong-A ST Co., Ltd Recent Developments
Table 64. Lupin Ltd Basic Information List
Table 65. Lupin Ltd Description and Business Overview
Table 66. Lupin Ltd Tuberculosis (TB) Treatment Products, Services and Solutions
Table 67. Revenue (US$ Million) in Tuberculosis (TB) Treatment Business of Lupin Ltd (2018-2023)
Table 68. Lupin Ltd Recent Developments
Table 69. Janssen Products, LP Basic Information List
Table 70. Janssen Products, LP Description and Business Overview
Table 71. Janssen Products, LP Tuberculosis (TB) Treatment Products, Services and Solutions
Table 72. Revenue (US$ Million) in Tuberculosis (TB) Treatment Business of Janssen Products, LP (2018-2023)
Table 73. Janssen Products, LP Recent Developments
Table 74. Mylan Basic Information List
Table 75. Mylan Description and Business Overview
Table 76. Mylan Tuberculosis (TB) Treatment Products, Services and Solutions
Table 77. Revenue (US$ Million) in Tuberculosis (TB) Treatment Business of Mylan (2018-2023)
Table 78. Mylan Recent Developments
Table 79. Sanofi Basic Information List
Table 80. Sanofi Description and Business Overview
Table 81. Sanofi Tuberculosis (TB) Treatment Products, Services and Solutions
Table 82. Revenue (US$ Million) in Tuberculosis (TB) Treatment Business of Sanofi (2018-2023)
Table 83. Sanofi Recent Developments
Table 84. North America Tuberculosis (TB) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 85. North America Tuberculosis (TB) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 86. Europe Tuberculosis (TB) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 87. Europe Tuberculosis (TB) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 88. Asia-Pacific Tuberculosis (TB) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 89. Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 90. Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 91. Asia-Pacific Tuberculosis (TB) Treatment Market Share by Region (2018-2023)
Table 92. Asia-Pacific Tuberculosis (TB) Treatment Market Share by Region (2024-2033)
Table 93. Latin America Tuberculosis (TB) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 94. Latin America Tuberculosis (TB) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 95. Latin America Tuberculosis (TB) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 96. Middle East & Africa Tuberculosis (TB) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 97. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 98. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 99. Tuberculosis (TB) Treatment Market Trends
Table 100. Tuberculosis (TB) Treatment Market Drivers
Table 101. Tuberculosis (TB) Treatment Market Challenges
Table 102. Tuberculosis (TB) Treatment Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis (TB) Treatment Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Tuberculosis (TB) Treatment Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Tuberculosis (TB) Treatment Market Share by Regions: 2022 VS 2033
Figure 4. Global Tuberculosis (TB) Treatment Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Tuberculosis (TB) Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Tuberculosis (TB) Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Tuberculosis (TB) Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Tuberculosis (TB) Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Tuberculosis (TB) Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Isoniazid
Figure 11. Global Isoniazid Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Rifampin (Rifadin, Rimactane)
Figure 13. Global Rifampin (Rifadin, Rimactane) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Ethambutol (Myambutol)
Figure 15. Global Ethambutol (Myambutol) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Pyrazinamide
Figure 17. Global Pyrazinamide Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Global Tuberculosis (TB) Treatment Market Size Share by Type: 2022 & 2033
Figure 19. North America Tuberculosis (TB) Treatment Revenue Market Share by Type (2018-2033)
Figure 20. Europe Tuberculosis (TB) Treatment Revenue Market Share by Type (2018-2033)
Figure 21. Asia-Pacific Tuberculosis (TB) Treatment Revenue Market Share by Type (2018-2033)
Figure 22. Latin America Tuberculosis (TB) Treatment Revenue Market Share by Type (2018-2033)
Figure 23. Middle East and Africa Tuberculosis (TB) Treatment Revenue Market Share by Type (2018-2033)
Figure 24. Active TB Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Latent TB Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 26. Global Tuberculosis (TB) Treatment Market Size Share by Application: 2022 & 2033
Figure 27. North America Tuberculosis (TB) Treatment Revenue Market Share by Application (2018-2033)
Figure 28. Europe Tuberculosis (TB) Treatment Revenue Market Share by Application (2018-2033)
Figure 29. Asia-Pacific Tuberculosis (TB) Treatment Revenue Market Share by Application (2018-2033)
Figure 30. Latin America Tuberculosis (TB) Treatment Revenue Market Share by Application (2018-2033)
Figure 31. Middle East and Africa Tuberculosis (TB) Treatment Revenue Market Share by Application (2018-2033)
Figure 32. Tuberculosis (TB) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 33. Global Top 5 and Top 10 Players Tuberculosis (TB) Treatment Market Share in 2022
Figure 34. North America Tuberculosis (TB) Treatment Market Share by Country (2018-2033)
Figure 35. U.S. Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 36. Canada Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 37. Germany Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 38. France Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 39. U.K. Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 40. Italy Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 41. Russia Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 42. Nordic Countries Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 43. Asia-Pacific Tuberculosis (TB) Treatment Market Share by Region (2018-2033)
Figure 44. China Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 45. Japan Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 46. South Korea Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 47. Southeast Asia Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 48. India Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 49. Australia Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 50. Latin America Tuberculosis (TB) Treatment Market Share by Country (2018-2033)
Figure 51. Mexico Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 52. Brazil Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 53. Middle East & Africa Tuberculosis (TB) Treatment Market Share by Country (2018-2033)
Figure 54. Turkey Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 56. UAE Tuberculosis (TB) Treatment Market Size (2018-2033) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report